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Abstract 
Cynara scolymus is a pharmacologically important medicinal plant containing phenolic acids and flavonoids. Experi-
mental studies indicate antioxidant and hepatoprotective effects of C. scolymus but there have been no studies 
about therapeutic effects of liver diseases yet. In the present study, hepatocurative effects of C. scolymus leaf extract 
on carbon tetrachloride (CCl4)-induced oxidative stress and hepatic injury in rats were investigated by serum hepatic 
enzyme levels, oxidative stress indicator (malondialdehyde-MDA), endogenous antioxidants, DNA fragmentation, p53, 
caspase 3 and histopathology. Animals were divided into six groups: control, olive oil, CCl4, C. scolymus leaf extract, 
recovery and curative. CCl4 was administered at a dose of 0.2 mL/kg twice daily on CCl4, recovery and curative groups. 
Cynara scolymus extract was given orally for 2 weeks at a dose of 1.5 g/kg after CCl4 application on the curative group. 
Significant decrease of serum alanine-aminotransferase (ALT) and aspartate-aminotransferase (AST) levels were 
determined in the curative group. MDA levels were significantly lower in the curative group. Significant increase of 
superoxide dismutase (SOD) and catalase (CAT) activity in the curative group was determined. In the curative group, 
C. scolymus leaf extract application caused the DNA % fragmentation, p53 and caspase 3 levels of liver tissues towards 
the normal range. Our results indicated that C. scolymus leaf extract has hepatocurative effects of on CCl4-induced 
oxidative stress and hepatic injury by reducing lipid peroxidation, providing affected antioxidant systems towards the 
normal range. It also had positive effects on the pathway of the regulatory mechanism allowing repair of DNA dam-
age on CCl4-induced hepatotoxicity.
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Background
The liver, the largest and most metabolically complex 
organ in the body, is involved in the metabolism of stor-
age and biosynthesis (Hodgson and Levi 2004). It is also 
responsible for detoxification and metabolic homeostasis 
(Shin et al. 2013). Because the liver is metabolically active 
and the fundamental organ of biotransformation and the 
metabolism, it is influenced by reactive oxygen species 
(ROS) produced in liver cells as the by-products of nor-
mal metabolism and detoxification reactions. Accord-
ingly, the liver has extensive antioxidant mechanisms 
to protect cells against ROS (Ellah 2011). However, the 
continuous and excessive production of ROS together 
with imbalances in endogenous antioxidant mechanisms 
causes oxidative stress. This stress induces damage to 
several biomolecules including lipids, proteins and DNA 
and, over time, contributes to liver injury. This injury 
is often differentiated as acute and chronic. Chronic 
liver disease has continuous formation from steatosis to 
chronic hepatitis, fibrosis, cirrhosis, and hepatocellular 
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carcinoma (Coballase-Urrutia et al. 2011; Loguercio and 
Federico 2003; Vitaglione et al. 2005). As a result of the 
continuous development of cirrhosis, the hepatic func-
tions of the liver are inhibited.
The plant Cynara scolymus L. (globe artichoke) is a 
pharmacologically important medicinal plant belong-
ing to the Asteraceae family (Lattanzio et  al. 2009; 
Mehmetçik et al. 2008); it is commonly grown in Medi-
terranean countries (Wang et  al. 2003). Artichoke 
leaves contain phenolic acids, sesquiterpene lactones, 
flavonoids, phytosterols (taraxasterol), sugars, inulin, 
enzymes, and essential oils (Lattanzio et al. 2009; Wang 
et  al. 2003; ESCOP 2003). The pharmacologically fun-
damental constituents of the leaf are phenolic acids 
and flavonoids. The phenolic acid derivatives include 
caffeoylquinic acids such as 3-caffeoylquinic acid, cyna-
rin, and caffeic acids. The flavonoid compounds of 
the leaf are luteolin-7-β-D-glucoside, luteolin-4-β-D-
glucoside and luteolin-7-β-rutinoside (Lattanzio et  al. 
2009; ESCOP 2003).
The leaf of the C. scolymus has been used for centu-
ries as an antimicrobial, anti-inflammatory, choleretic, 
hepatoprotective, cholesterol-lowering, lipid-lowering, 
and glucose-lowering substance in Turkey, Southern 
Europe and Mediterranean countries (Lattanzio et  al. 
2009; Jimenez-Escrig et  al. 2003). Several in  vivo and 
in  vitro studies have been conducted to examine the 
applications of C. scolymus leaves. As a result of these 
studies -in addition to the traditional usage- anti-carcino-
genic, anti-apoptotic and anti-HIV characteristics were 
also determined (Miccadei et  al. 2008; Robinson et  al. 
1996; Yang et al. 2001). The reason for the extensive usage 
of the leaf of the C. scolymus is described as being due 
to the additive and synergistic effects of the various com-
pounds in the structure.
There have been several studies associated with liver 
pathology and the C. scolymus leaf extract. Gebhardt 
(1997) demonstrated the antioxidant and hepatopro-
tective effects of the C. scolymus leaf extract in primary 
cultured rat hepatocytes (Gebhardt 1997). Additionally, 
in a study with human leukocyte cultures, caffeic acid-, 
chlorogenic acid-, cynarin- and lutein-containing C. sco-
lymus leaf extracts have been reported to have antioxida-
tive effects, with the C. scolymus leaf extract expressing 
its antioxidant affects as a radical scavenger and a PMA-
induced radical generation inhibitor (Pérez-García et al. 
2000). Furthermore, as a result of in vivo studies in rats, 
the C. scolymus leaf extract has been suggested to reduce 
lipid peroxidation (Speroni et  al. 2003) and protein oxi-
dation as well as increase glutathione peroxidase activity 
(Jimenez-Escrig et  al. 2003). Although there are several 
in  vivo and in  vitro studies regarding the hepatoprotec-
tive effects of the C. scolymus leaf extract, none of the 
studies describe its hepatocurative effects. The present 
study has been carried out to investigate the curative 
roles of the C. scolymus leaf extract against CCl4-induced 
oxidative stress and hepatic injury in rats. To determine 
and exhibit the oxidative stress after application of CCl4 
and to evaluate the therapeutic effect of C. scolymus 
leaf extract; ALT and AST, the biochemical markers of 
liver damage, were measured. The severe hepatic dam-
age caused by CCl4 toxicity was determined and also the 
therapeutic effects of the C. scolymus leaf extract were 
evaluated by measuring the level of the oxidative stress 
indicator MDA, the activities of endogenous antioxidants 
superoxide dismutase (SOD) and catalase (CAT). DNA 
fragmentation, p53 and caspase 3 levels were identified 
to determine the therapeutic effects of the C. scolymus 
extract on cell proliferation, apoptosis, DNA damage and 
homeostasis changes which were caused by CCl4 toxicity.
Results
Cynara scolymus leaf extract effects on serum hepatic 
enzyme levels
As shown in Table  1, the serum AST and ALT levels 
were significantly higher (P  <  0.001) in the 0.2  mL/kg 
CCl4 group after the CCl4 administration, and significant 
decreases in the serum AST and ALT levels (P < 0.001) 
were obtained compared with the 0.2 mL/kg CCl4 group 
after the C. scolymus leaf extract (1.5  g/kg/day) appli-
cation on the curative group. AST an ALT levels were 
decreased 37 and 49 % in the recovery group compared 
with 0.2 mL/kg CCl4 group. In the same duration, serum 
levels of AST and ALT were decrease by 40 and 52  % 
respectively in curative group compared with 0.2 mL/kg 
CCl4 group.
Cynara scolymus leaf extract effects on the MDA levels, 
SOD and CAT activity of the liver tissue
The hepatocurative effects of C. scolymus leaf extracts 
on MDA levels, SOD and CAT activity of the liver tissue 
are shown in Table 2. MDA levels were increased signifi-
cantly after the CCl4 application (P  <  0.001). MDA lev-
els were significantly lower after the application of the C. 
scolymus leaf extract in the curative group (P  <  0.001). 
Moreover, there was a significant decrease in MDA 
found in the curative group versus the recovery group 
(P < 0.01). Administration of CCl4 decreased SOD activ-
ity (P  <  0.001) significantly when compared to control 
group levels. Also significant decrease on the SOD activ-
ity of the recovery and curative groups were determined 
compared with both the control and 0.2  mL/kg CCl4 
groups. The recovery group’s SOD activity decreased 
significantly versus the curative group (P < 0.001). SOD 
activity was decreased in the Cynara extract group with-
out CCl4 application. This was an unexpected result but 
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in this group MDA level was also significantly increased 
compared to control group and this demonstrated the 
lipid peroxidation that may be decreased the antioxidant 
activity of SOD. So that results need further investigation. 
Administration of CCl4 also significantly decreased CAT 
activity (P < 0.001) than that of the control group. After 
the application of the C. scolymus leaf extract, there was 
a significant increase (P  <  0.001) observed in the cura-
tive group compared with both the recovery (P < 0.001) 
and 0.2 mL/kg CCl4 (P < 0.001) groups. This significant 
increase was also determined on the CAT level of the C. 
scolymus leaf extract group.
Cynara scolymus leaf extract effects on DNA % 
fragmentation, p53 and caspase 3 levels of the liver tissue
The hepatocurative effects of C. scolymus leaf extracts 
on DNA  % fragmentation, p53 and caspase 3 levels of 
the liver tissue are shown in Table 3. DNA % fragmenta-
tion, p53 and caspase 3 levels of the liver tissue increased 
significantly (P  <  0.001) after the application of CCl4 
compared with the control group. Treatment of CCl4 
hepatotoxicity with the C. scolymus leaf extract decreased 
the DNA % fragmentation, p53 and caspase 3 levels sig-
nificantly (P < 0.001). Compared with the recovery group, 
significant decreases of DNA % fragmentation (P < 0.01), 
p53 (P < 0.05) and caspase 3 (P < 0.001) levels of the liver 
tissues were obtained in the curative group. Our results 
also demonstrated that C. scolymus leaf extract applica-
tion alone without CCl4 did not indicate any significant 
variation of DNA damage, p53 and caspase 3 levels.
Cynara scolymus leaf extract effects on histological 
changes of the liver tissues
The hepatocurative effects of C. scolymus leaf extracts 
on histological changes of the liver tissues are shown 
in Fig. 1. The liver tissue samples of the 0.2 mL/kg CCl4 
group exhibited remarkable damage. Irregularities were 
observed in the parenchymal structure, and the classic 
Table 1 Serum levels of AST and ALT
* P < 0.05, ** P < 0.01, *** P < 0.001 values are compared with the control group
+  P < 0.05, ++ P < 0.01, +++ P < 0.001 values are compared with the CCl4 group
Groups (n = 7) AST (U/l) ALT (U/l)
Control 184.14 ± 5.78+++ 70.71 ± 6.24+++
Olive oil 284.00 ± 32.10***, +++ 117.71 ± 26.56***, +++
Cynara extract 248.42 ± 19.68***, +++ 78.86 ± 16.23+++
0.2 ml/kg CCl4 342.14 ± 21.42*** 201.00 ± 9.74***
Recovery 213.57 ± 10.45*, +++ 101.00 ± 8.92***, +++
Curative 202.42 ± 21.57+++ 96.43 ± 7.28***, +++
Table 2 MDA, SOD and CAT levels of liver tissues
* P < 0.05, ** P < 0.01, *** P < 0.001 values are compared with the control group
+  P < 0.05, ++ P < 0.01, +++ P < 0.001 values are compared with the CCl4 group
a  P < 0.01, b P < 0.001 values compared between recovery and curative group
Groups (n = 7) MDA (nmol/g protein) SOD (% inhibition) CAT (kU/gr protein)
Control 0.36 ± 0.02+++ 57.57 ± 1.13 2.89 ± 0.40+++
Olive oil 0.75 ± 0.04***, +++ 55.43 ± 6.07***, +++ 2.75 ± 0.19+++
Cynara extract 0.66 ± 0.02***, +++ 33.57 ± 3.73***, +++ 4.10 ± 0.70**, +++
0.2 ml/kg CCl4 1.04 ± 0.22*** 46.57 ± 2.69*** 1.43 ± 0.30***
Recovery 0.81 ± 0.16***, +++ 31.00 ± 2.64***, +++ 1.51 ± 0.49***
Curative 0.60 ± 0.08***, +++, a 38.57 ± 3.21***, +++, b 3.94 ± 0.37***, +++, b
Table 3 DNA fragmentation, p53 and caspase 3 levels of liver tissues
* P < 0.05, ** P < 0.01, *** P < 0.001 values are compared with the control group
+  P < 0.05, ++ P < 0.01, +++ P < 0.001 values are compared with the CCl4 group
a  P < 0.05, b P < 0.01, c P < 0.001 values compared between recovery and curative group
Groups (n = 7) DNA fragmentation (%) p53 (pg/ml) Caspase 3 (ng/
ml)
Control 20.11 ± 2.69+++ 55.53 ± 0.93+++ 5.03 ± 0.73+++
Olive oil 20.21 ± 0.82+++ 53.34 ± 0.84+++ 5.11 ± 0.85+++
Cynara extract 20.07 ± 1.83+++ 55.90 ± 7.94+++ 4.67 ± 0.29+++
0.2 ml/kg CCl4 33.96 ± 0.35*** 112.39 ± 0.20*** 7.42 ± 0.12***
Recovery 29.18 ± 2.61***, +++ 71.74 ± 10.39***, +++ 6.75 ± 0.29***
Curative 25.66 ± 2.15***, +++, b 61.96 ± 5.96+++, a 5.04 ± 0.13+++, c
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lobular structure could not be distinguished. In addition, 
sinusoidal dilation (++), congestion (+), inflammation 
(++), intense degeneration (+++), vacuolisation, nod-
ular types of cellular damage (+++), pycnotic nuclei of 
necrotic cells with eosinophilic cytoplasm (+++) and 
hypertrophic cell structures (+++) were observed. In 
the recovery group, sinusoidal dilation (+), inflamma-
tion (+), congestion (+) and cellular damage (+) were 
observed. Sinusoidal dilation (+) and congestion (+) 
were examined in the curative group.
Discussion
The liver plays several important roles in the metabolism, 
including the biosynthesis of plasma proteins, gluconeo-
genesis and detoxification. Although the liver has strong 
regeneration capability, a specific amount of tissue loss 
prevents its ability to regenerate, and liver disease ensues 
(Xu et al. 2011).
Carbon tetrachloride (CCl4) is a well-known and widely 
used model for induced liver injury studies (Mir et  al. 
2010). CCl4 is a biologically inactive and stable substance 
that is chemically produced (Khan et al. 2012; Kose et al. 
2005). It is transformed into reactive toxic metabo-
lites by the cytochrome P-450 system in the liver. Dur-
ing this process, it is first converted to trichloromethyl 
by the cytochrome P-450 system. Then, in the presence 
of oxygen, it is rapidly transformed into trichloromethyl 
peroxide and chloroform, chemical configurations that 
have lost their hydrogen atoms. This free radical pro-
duction overcomes the antioxidant defences of the liver 
and causes the oxidative destruction of cell membranes, 
resulting in serious liver tissue damage (Ajiboye 2010; 
Fig. 1 Histological investigations of the liver tissues. a, b Hemotoxylin and eosin-stained liver section of the control group (v vena sentralis, a X10, 
b X20). c, d Cynara scolymus leaf extract group (c, d X10). e–h CCl4 group; vacuolisation (e thin arrow, X20) sinusoidal dilation (f arrow), intense 
degeneration, nodular types of cellular damage (g *) necrotic cells and pyknotic nuclei of necrotic cells with eosinophilic cytoplasm (h arrowhead) 
a hypertrophic cell structures (h black arrow, X40,100). i, j: Recovery group (i X20, j X40). k, l Curative group; partial degeneration (arrowhead) and 
sinusoidal dilation (arrow) were examined (k X10, l X20)
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Lima et al. 2007; Recknagel 1967) and one of the funda-
mental causes of CCl4 hepatotoxicity is the lipid peroxi-
dative degradation of membranes (Srivastava et al. 1990). 
Damaged liver cells secrete liver specific enzymes into 
the bloodstream. These secreted enzymes, such as AST 
and ALT, are frequently used as biochemical indicators 
of liver damage and also play an important role in the 
investigation of the effects of therapeutic agents (Wallace 
and Meyer 2010; Mir et al. 2010; Lima et al. 2007). In the 
present study, the levels of AST and ALT were higher in 
the 0.2  mL/kg CCl4 group. The C. scolymus leaf extract 
(1.5  g/kg/day) application after the induction of liver 
injury by CCl4 resulted in decreased AST and ALT levels 
but there were no significant differences found between 
the recovery and curative groups. Although statisti-
cal sense was not obtained, in the same duration lower 
AST and ALT levels in curative group demonstrated that 
C. scolymus leaf extract accelerates the renewal mecha-
nism of the liver. All these results indicated that there 
was a re-stabilization of the cell membranes and repair 
mechanisms in the hepatic tissue as a result of recov-
ery against the oxidative stress more rapidly because of 
the in vivo antioxidant properties of the C. scolymus leaf 
extract. These results were also confirmed by MDA lev-
els and histopathological evaluations in the current study. 
MDA, the end product of lipid peroxidation, is used as an 
oxidative stress indicator. In the present study, liver tis-
sue MDA levels were higher in the 0.2 mL/kg CCl4 group 
after the induction of hepatocellular injury, and the C. 
scolymus leaf extract was found to decrease the levels of 
liver tissue MDA more than the recovery itself, presum-
ably due to cell membrane repair.
In order to respond to oxidative stress, biological sys-
tems protect themselves with endogenous antioxidants 
such as catalase (CAT), glutathione (GSH), paraoxo-
nase-1 (PON1), and arylesterase in the liver (Özbayer 
et al. 2011; El-Sayed et al. 2015). These antioxidants have 
important roles in the detoxification of free radicals and 
ROS resulting exposure of the various toxic chemicals 
and xenobiotics (Ajiboye 2010). The antioxidant GSH 
directly scavenges ROS and free radicals and as a part of 
the GSH redox system protecting biological systems from 
oxidative stress (El-Sayed et  al. 2015). SOD, the endog-
enous antioxidant enzyme, catalyses the dismutation of 
the superoxide radical into molecular oxygen and hydro-
gen peroxide. CAT, an important antioxidant enzyme for 
the protection of the cells from oxidative damage caused 
by ROS, catalyses the reaction of hydrogen peroxide to 
water and molecular oxygen (Hsiao et  al. 2001). Anti-
oxidant enzymes are easily inactivated by lipid perox-
ides or reactive oxygen species (Coballase-Urrutia et  al. 
2011) and the decreases of these antioxidant enzymes in 
the cells cause failure in the defence and result in liver 
damage (Ajiboye 2010; El-Sayed et al. 2015). In addition, 
decreases of the GSH, SOD and CAT activity of the liver 
tissues after the application of CCl4 have been described 
previously (El-Sayed et al. 2015; Ajiboye 2010; Coballase-
Urrutia et al. 2011; Cuciureanu et al. 2009). In the present 
study, we demonstrated that CCl4 induced a significant 
decrease the activity of SOD and it was also determined 
that this reduction continued in the recovery group that 
did not receive treatment after CCl4 administration. 
Treatment with the C. scolymus leaf extract elevated the 
decreased levels of SOD activity and markedly reduced 
the hepatotoxicity of CCl4 compared with both 0.2 mL/
kg CCl4 and recovery group. In the present study, the 
significant depletion of CAT level in the 0.2 mL/kg CCl4 
group and the significant increase of the activity of CAT 
in the curative group after the application of the C. sco-
lymus leaf extract were also demonstrated. The applica-
tion of the C. scolymus leaf extract increased the activity 
of CAT in the liver tissue towards the normal range in the 
curative group. These results suggested that as a result of 
CCl4 hepatotoxicity, endogenous antioxidant SOD and 
CAT activities would be decreased in cases where the 
external reinforcement was not supplied although liver 
has self-recovery mechanism and C. scolymus leaf extract 
attenuated CCl4-induced hepatotoxicity.
CCl4 application produced ROS and free radicals, capa-
ble of producing oxidative DNA damage. Reactive inter-
mediates resulting from the transformation of CCl4 bind 
to DNA covalently, resulting in the oxidation of DNA 
(Lavanya et  al. 2009). This oxidative damage causes the 
formation of DNA adducts, genetic mutations, strand 
breakage and chromosomal alterations (Mir et  al. 2010; 
Khan et al. 2012). The formation of DNA damages affect 
homeostasis of the cells and induced signal transduc-
tions associated with apoptosis and cell proliferation. 
In response to DNA damage triggers the tumour sup-
pressor gene p53 expression and the protein product of 
p53 blocks the cell cycle in the G1 phase for repairing 
the DNA (van Gijssel et  al. 1997). When the damage is 
severe, it triggers the apoptosis. There is not only DNA 
damage but also cytochrome c is released from the mito-
chondria as a result of the oxidative damage and this 
pathway also activates the p53 and caspases (Campo et al. 
2008). Our results showed that CCl4 induced high lev-
els of DNA fragmentation; p53 and caspase 3 in the rat 
liver and the application of the C. scolymus leaf extract as 
a treatment decreased them more in the curative group 
than in the recovery group.
Several studies have reported that application of CCl4 
lead to a variety of structural changes in the liver tis-
sue such as sinusoid dilation, congestion, inflammation, 
intense degeneration, vacuolisation, nodular types of 
cellular damage, pyknotic nuclei of necrotic cells with 
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eosinophilic cytoplasm and hypertrophic cell structures 
(Mehmetçik et  al. 2008; Hsiao et  al. 2001; Cuciureanu 
et al. 2009). In this study, we observed similar histomor-
phological changes in CCl4 group. Irregularities were 
observed in the parenchymal structure, and the classic 
lobular structure could not be distinguished. Severe sinu-
soidal dilation, congestion, inflammation, intense degen-
eration, vacuolisation, nodular types of cellular damage, 
pycnotic nuclei of necrotic cells with eosinophilic cyto-
plasm and hypertrophic cell structures were observed in 
this group. Following the CCl4 induced hepatic injury, 
the application of C. scolymus leaf extract led to a reduc-
tion of these damages more than that of the recovery 
group and mild sinusoidal dilation and congestion were 
detected in curative group.
All the achieved results demonstrated that C. scolymus 
leaf extract used against liver injury induced by CCl4 has 
antioxidant and anti-apoptotic properties. The effective-
ness of the leaf extract against liver diseases is due to the 
phenolic acids and flavonoids. While the phenolic acids 
possess a good anti-oxidant activity against peroxyl and 
hydroxyl radicals, flavonoids act as hydrogen donors and 
metal ion chelators (Lattanzio et al. 2009).
Conclusions
The present study indicated that the C. scolymus leaf 
extract reduced the lipid peroxidation, provided the 
affected antioxidant systems towards the normal range 
and had positive effects on the pathway of regulatory 
mechanism allowing repair of DNA damage on CCl4 
induced hepatotoxicity. These results suggested that the 
C. scolymus leaf extract may be used as a pharmaceutical 
phytomedicine in the treatment of liver diseases.
Methods
Plant material
5 % cynarin containing, commercially available C. scoly-
mus leaf extract powder extracted with 75 % ethanol was 
purchased from Kale Naturel Herbal Products Company, 
Ltd., Balikesir, Turkey.
Chemicals and reagents
CCl4, 30  % hydrogen peroxide (H2O2), 1,1,3,3 tetraeth-
oxy propane, 2-mercaptoethanol, ammonium molybdate, 
and n-butanol were purchased from Sigma Chemical Co. 
(St. Louis, MO, USA). Phosphoric acid (H2PO4), hydro-
chloric acid (HCl), potassium chloride (KCl), potas-
sium phosphate (KH2PO4), xylene, potassium phosphate 
monobasic (Na2HPO4), sodium carbonate (Na2CO3), and 
thiobarbituric acid (TBA) were purchased from Merck 
KGaA (Germany). Polyethylene glycol tert-octylphe-
nyl ether (Triton X-100) was purchased from Electron 
Microscopy Sciences (USA-Hatfield, PA). The SOD 
determination kit (19160; Fluka, Hannover, Germany) 
and Total Protein Liquicolor (10570; Human GmbH, 
Germany) were used. The remainder of the chemicals 
used were of a highly pure grade.
Experimental animals
Forty-two Sprague–Dawley male rats weighing 
267.83 ± 25.81 g were used for the study. All of the ani-
mals were kept under identical laboratory conditions, 
including temperature (22 ± 2 °C) and lighting (12: 12 h 
light: dark cycle). The rats were fed with standard labora-
tory chow and tap water ad libitum. All of the rats were 
allowed to acclimatize for one week prior to the experi-
mentation. The study was carried out in accordance with 
the guidelines of the Eskisehir Osmangazi University 
Local Ethics Committee of Animal Experiments.
Experimental design
After acclimatization, the animals were randomly 
divided into six experimental groups (n  =  7 rats per 
group) including the control, olive oil, 0.2 mL/kg CCl4, 
C. scolymus leaf extract, recovery and curative groups. 
In order to establish a normal control, the control group 
rats received saline only (0.2 mL/kg i.p.) for 10 days and 
tap water orally for 2  weeks. For the vehicle control, 
the olive oil group rats received olive oil only (0.2 mL/
kg) for 2  weeks. During the first 10  days of the study, 
the 0.2  mL/kg CCl4, the recovery and curative group 
rats were intraperitoneally injected with CCl4 at a dose 
of 0.2  mL/kg in 50  % olive oil solution twice daily to 
induce liver injury as previously described (Hülyam 
et  al. 2005; Rikans et  al. 1994). After the CCl4 admin-
istration, the 0.2 mL/kg CCl4 group rats were sacrificed 
to determine the extent of the liver injury. The curative 
group rats were given C. scolymus leaf extract orally 
for 2 weeks at a dose of 1.5 g/kg dissolved in tap water 
after the CCl4 administration. After the CCl4 adminis-
tration, to investigate the long term effects of CCl4 and 
to evaluate the self-recovery mechanism of liver, rats in 
the recovery group did not receive any drugs or treat-
ment for 2 weeks. The C. scolymus leaf extract (1.5 g/kg) 
was dissolved in tap water and applied orally to the C. 
scolymus leaf extract group rats for 2 weeks without any 
CCl4 administration. In the current study the basis of 
C. scolymus leaf extract dose in 1.5 g/kg determination 
depending on the specified studies about hepatoprotec-
tive effects reported the effect of C. scolymus extract at a 
dose of 1.5 g/kg was more prominent than that of lower 
doses (Mehmetçik et  al. 2008; Küskü-Kiraz et  al. 2010; 
Afifi et al. 2014). The rats were anesthetised with ether 
24 h after the final treatments.
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Blood and tissue collection and preparation for assays
Blood was withdrawn from the rats under ether anaes-
thesia 24 h after the final treatments. Blood samples were 
collected from the inferior vena cava to the proper tubes. 
The blood was centrifuged at 2063 ×g for 15 min at 4 °C, 
and the serum was obtained to determine liver function.
After sacrificing the rats by bleeding, their livers were 
carefully dissected and cleared of extraneous tissue, and 
the samples were divided into two parts for separate 
uses. One part of the liver tissue was immediately trans-
ferred into 10 % formalin for histopathological investiga-
tion. The other parts were immediately stored at −80 °C 
to obtain homogenates for the analysis of SOD, CAT, 
MDA, DNA fragmentation and protein determination. 
These samples were homogenised in potassium chlo-
ride (1 %) using an ultrasonic homogeniser. The liver tis-
sue homogenate was centrifuged at 3 667 ×g for 15 min 
at 4  °C. The obtained supernatant was stored at −80  °C 
until the studies commenced.
Measurements of ALT and AST in the rat serum
The serum levels of ALT and AST were determined by a 
Roche Modular P chemistry analyser (Roche Diagnostics, 
9115 Hague Road, Indianapolis, IN 46250). Product test 
kits were supplied by Roche (Roche Diagnostics, 9115 
Hague Road, Indianapolis, IN 46250).
Protein determination
The amount of total protein in the liver tissue was 
determined spectrophotometrically by a total protein 
kit (Total Protein Liquicolor 10 570, Wiesbaden, Ger-
many) designed in accordance with the Biuret Protein 
Assay method, and the resulting values were used for 
the levels of MDA and CAT activity in the liver tissue 
homogenates.
Estimation of lipid peroxidation
Lipid peroxidation, in terms of MDA production (thio-
barbituric acid-reactive species), was determined as pre-
viously described (Uchiyama and Mihara 1978). Briefly, 
0.1 mL of liver homogenate samples, 3 mL of 1 % phos-
phoric acid, and 1 mL of 0.6 % 2-thiobarbituric acid were 
used. For a blank, 0.1 mL of distilled water was used. The 
mixture was boiled in a water bath for 45 min followed 
by cooling in ice and the addition of 4 mL of n-butanol 
to extract the cold thiobarbituric acid reactants. After 
cooling, 4 mL of n-butanol was added, and the samples 
were shaken. The butanol layer was separated by cen-
trifugation at 2 808 ×g for 5 min. The optical density of 
the n-butanol layer was determined at 532 nm on a spec-
trophotometer (Shimadzu UV-1601 digital spectropho-
tometer, Schimadzu Corp., Kyoto, Japan). A standard 
curve of MDA was constructed using concentrations of 
10, 8, 6, 4, 2, and 1 nmol. The lipid peroxidation activities 
are expressed as nmol/g of wet tissue for the liver tissue 
homogenates.
Estimation of superoxide dismutase (SOD) and catalase 
(CAT) activity of the liver tissue
The SOD enzyme activity in the liver tissue samples was 
measured using a SOD determination kit (FLUKA, St. 
Louis, MO, Cat. No: 19160). The kit uses a highly water-
soluble tetrazolium salt, WST-1 (2-(4-lodophenyl)-3-
(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, 
monosodium salt), which produces a water-soluble 
formazan dye upon being reduced by superoxide anions. 
Briefly, 20 μL of sample solution, 200 μL of WST-1 work-
ing solution and 20 μL of enzyme working solution were 
added to each well of a 96-well microplate and incubated 
at 37 °C for 20 min to produce a water-soluble formazan 
dye. The absorbance at 450  nm was measured using an 
enzyme-linked immunosorbent assay plate reader (Lab-
systems Multiskan EX; Thermo Labsystems, Finland, 
Vartaa, Finland). SOD activity (inhibition rate) was calcu-
lated using the formula {[(Ablank 1–Ablank 3)—Asam-
ple–Ablank 2)]/(Ablank 1–Ablank 3)} × 100.
The CAT activity of the samples was determined 
according to the method described previously (Goth 
1991). Briefly, the supernatant was incubated in the 
substrate solution containing H2O2 (65  μmol per mL in 
50 mmol/L phosphate buffer, pH 7.0) in a water bath at 
37 °C for 60s. The enzymatic reaction was blocked by the 
addition of ammonium molybdate, and a yellow complex 
of hydrogen peroxide was obtained. The absorbance of 
this yellow complex was measured at 405 nm using the 
spectrophotometer.
Determination of DNA fragmentation in the liver tissue
DNA fragmentation was determined using a spectro-
photometric assay method based on the diphenylamine 
(DPA) reaction, which binds to deoxyribose (Hickey 
et  al. 2001). In order to measure liver DNA fragmenta-
tion by spectrophotometry, 0.3  g of frozen liver was 
homogenised in a chilled lysis buffer (5  mmol/L Tris–
HCl, 20 mmol/L EDTA, 0.5 % Triton X-100, pH 8). The 
homogenates were centrifuged at 26 000 ×g for 25 min 
to separate the intact DNA in the pellet from the frag-
mented DNA in the supernatant. The pellets were re-
suspended in 0.5 mol/L perchloric acid. In order to reach 
a final concentration of 0.5 mol/L, 1917 µL of the super-
natants were treated with 86 µL of concentrated perchlo-
ric acid. All of the samples were incubated at 90  °C for 
15  min and centrifuged at 750 ×g for 10  min to obtain 
the supernatants. The supernatants and DNA stand-
ards at various concentrations were treated with diphe-
nylamine and incubated for 18  h at room temperature. 
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The absorbance of the samples and standards were meas-
ured at 600  nm. The percentage of DNA fragmentation 
was calculated using the formula fragmented DNA/(frag-
mented DNA + intact DNA).
p53 levels in the liver tissue
The p53 pan ELISA kit was used for determine the lev-
els of p53 protein (Roche Molecular Biochemicals, 
Germany, Cat. No: 11828789001). The p53 pan ELISA 
assay is based on the quantitative “sandwich enzyme-
immunoassay” principle using two monoclonal anti-
bodies directed against rat p53. Briefly, 1  g of weighed 
liver tissue samples was homogenized in ice cold RIPA 
buffer (low-salt) containing 20 mmol/L Tris, 0.5 mmol/L 
EDTA, 1  % Nonidet P40, 0.5  % sodium deoxycholate, 
0.05  % sodium dodecyl sulphate, 1  mmol/L phenyl-
methylsulphonylfluoride, 1  µg/mL aprotinin, and 2  µg/
mL leupeptin. The homogenate was centrifuged at 10 
000  ×g for 10  min at 4  °C. The resulting supernatants 
were collected and diluted 1:5 with sample diluent to 
prepare samples. The samples were transferred to a 
streptavidin-coated microtiter plate with an anti-rat-
p53 polyclonal antibody. p53 from the sample binds to 
the plate surface, and the peroxidase (POD)-conjugated 
detection antibody interacts with the immobilized p53. 
Following a washing step, the POD bound within the 
“sandwich” complex is detected with the colorimetric 
substrate tetramethylbenzidine and levels are spectro-
photometrically determined at 450 nm with a microplate 
reader. Sample concentrations were determined from 
calibration curve and tissue p53 concentrations were 
expressed as pg/mL.
Caspase 3 levels in the liver tissue
USCN Life Science Inc. caspase 3 ELISA kit (Cat. No: 
SEA626Ra) was used to measure caspase 3 concentra-
tions in the liver tissues. Briefly, the liver tissues (1 g) were 
homogenized in ice cold PBS (0.02  mol/L, pH 7.0) and 
then centrifuged at 5 000 ×g at 4 °C for 5 min. Standards 
and samples were added to the appropriate microtiter 
plate wells with a biotin-conjugated antibody specific to 
caspase 3. Avidin conjugated to Horseradish Peroxidase 
(HRP) was added to each microplate well and incubated. 
After TMB substrate solution was added, biotin-conju-
gated antibody and enzyme-conjugated Avidin showed 
a change in colour. The enzyme-substrate reaction was 
terminated by the addition of sulphuric acid solution and 
the colour change was measured spectrophotometrically 
at a wavelength of 450 nm. The concentrations of caspase 
3 in the samples were then determined by comparing the 
O.D. of the samples to the standard curve. Levels were 
expressed as ng/mL.
Histopathological evaluation
The livers were routinely processed in 10  % forma-
lin solution and embedded in paraffin. Tissue Sections 
(5 μm) were obtained and stained with haematoxylin and 
eosin (H&E). The histopathological examinations were 
performed under a light microscope (NIKON, Japan). All 
of the histopathological examinations were performed by 
a histologist who was blinded to all of the tissue speci-
mens. Samples were evaluated as (+) less damaged, (++) 
moderately damaged, (+++) severely damaged.
Statistical analysis
The normality of the continuous variables was tested 
with the Kolmogorov–Smirnov test. Normally distrib-
uted variables were compared between groups using a 
one-way analysis of variance (ANOVA) with Tukey’s test. 
All results are expressed as mean ± SD (standard devia-
tion). P values less than 0.05 were considered significant. 
Data analyses were performed using SPSS version 15.0.
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